BIORA THERAPEUTICS, INC.: Nasdaq/NYSE listing notice — Biora Therapeutics receives Nasdaq delisting notice for failing $50M assets/revenue requirement

BIORA THERAPEUTICS, INC.

Notice on April 4, 2023: Nasdaq Staff says BIOR no longer meets $50M total assets and $50M total revenue requirement.
No immediate delisting; company has 45 days (by May 19, 2023) to submit plan to regain compliance.
If plan accepted, Staff may grant up to 180 days (through Oct 2, 2023) to evidence compliance.
If plan not accepted, Staff issues delisting determination; appeal to Hearings Panel stays delisting.
Company evaluating options but no assurance of extension or regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BIORA THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding other (rules 5450(b)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5450(b)

Exact text from the filing

April 4, 2023, Biora Therapeutics, Inc. (the “ Company ”) received formal notice from the Listing Qualifications Staff (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company no longer satisfies the $50 million in total assets and $50 million in total revenue requirement for continued listing on The Nasdaq Global Market or the alternative criteria under Nasdaq Listing Rule 5450(b) (the “ Rule ”). The Staff’s notice has no immediate effect on the listing of the Company’s common stock, which the Company expects will continue to trade on Nasdaq in the normal course

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-095373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.